Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.
Also called NCT01850160
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 124 participants
- Sponsor
- Farma de Colombia SA
- Registry
-
NCT01850160
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Colombia, Ecuador
- Registry status
- Completed
Technical summary
Registry record NCT01850160. Randomized; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- GROUP A: Valsartan plus Chlorthalidone
- Intervention (Drug)
- GROUP B: Valsartan
- Intervention (Drug)
- GROUP C: Chlorthalidone
- Lead sponsor
- Farma de Colombia SA
Record details
- Record id
cardio:ct-nct01850160- Content hash
c3197e05f942e6891c67887c7960a68b2845e42c3ecd278c08e858fd79492540